Not Signed In - Barr Receives Approvable Letter for Duramed''s SEASONIQUE(TM) Extended-Cycle Oral Contraceptive
Sun, 21 Aug 2005 11:00 PM EST
... Barr Pharmaceuticals, Inc confirmed that the US Food and Drug Administration (FDA) has issued an Approvable letter for Duramed Pharmaceuticals, Inc''s New Drug Application (NDA) for SEASONIQUE(TM) (levonorgestrel/ethinyl estradiol tablets 0... click link for more info. ...
Related Topics
- Epstein Barr Virus
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Oral Cancer
- Referral
- Oral Health
- Frequent infections especially with Epstein-Barr virus
- Epstein-Barr Virus (EBV) Infection
- Medroxyprogesterone Contraceptive Injection
- Iud
- Niacin Extended Release
- Lovastatin Extended Release
- Thrombophlebitis
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Amoxicillin Oral Suspension
- Zidovudine Oral Syrup
- Liothyronine
- Phosphorus
- Depo-provera
- Hereditary urea cycle abnormality
- Bismuth Subsalicylate Oral Liquid
email this page
print this page
bookmark this page
feedback on this page
